Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-09-13
1998-12-22
Grimes, Eric
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 7, 530350, A61K 3817
Patent
active
058519912
ABSTRACT:
This invention provides a method of preventing or inhibiting the proliferation of a pathologically proliferating cell, wherein the pathological proliferation of the cell is the result of the absence of a functional retinoblastoma protein or polypeptide in the cell. The method requires contacting the cell with an effective amount of retinoblastoma protein or polypeptide. This method also is useful to prevent or treat retinoblastoma or a secondary cancer to retinoblastoma by administering to a patient a functional retinoblastoma protein or polypeptide.
REFERENCES:
patent: 4497796 (1985-02-01), Salser et al.
patent: 4736866 (1988-04-01), Leder et al.
patent: 4783313 (1988-11-01), Makari et al.
patent: 4803072 (1989-02-01), Dalton et al.
patent: 4851341 (1989-07-01), Hopp et al.
patent: 4942123 (1990-07-01), Lee et al.
patent: 5011773 (1991-04-01), Lee et al.
Madraperla et al., Cancer Res. 51:6381-6384 (1991).
Wang et al., Oncogene 8:279-288 (1993).
Lee, et al., "The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity." Nature 329:642-645 (1987).
Levine, Arnold, "The Tumor Suppressor Genes." Annu. Rev. Biochem. 62:623-651 (1993).
Ludlow, et al., "SV40 Large T Antigen Binds Preferentially to an Underphosporylated Member of the Retinoblastoma Susceptibility Gene Product Family." Cell 56:57-65 (1989).
Lundberg, et al., "Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosomes 13." Proceedings of the National Academy of Sciences 84:2372-2376 (1987).
Mann, et al., "Construction of a Retrovirus Packaging Mutant and Its Use to Produce Helper-Free Defective Retrovirus." Cell 33:153-159 (1983).
Matsuura, "Baculovirus Expression Vectors: the Requirements for High Level Expression of Proteins, Including Glycoproteins." J. Gen. Virol. 68:1233-1250 (1987).
McCune, et al., "The SCID-hu Mouse: Murine Model for the Analysis of Human Hematolymphoid Differentiation and Function." Science 241: 1632-1639 (1988).
Mendoza, et al., "A Case of Synovial Sarcoma with Abnormal Expression of the Human Retinoblastoma Susceptibiltiy Gene." Human Pathology 19:487-489 (1988).
Mihara, et al., "Cell Cycle-Dependent Regulation of Phosphorylation of the Human Retinoblastoma Gene Product." Science 246:1300-1303 (1989).
Hooper, et al., "HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells." Nature 326:292-295 (1987).
Horowitz, et al., "Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cell." Proceedings of the National Academy of Sciences 87:2775-2779 (1990).
Horowitz, et al., "Point Mutational Inactivation of the Retinoblastoma Antioncogene." Science 243:937-940 (1989).
Hu, et al., "The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations." The EMBO Journal 9(4):1147-1155 (1990).
Huang, et al., "Suppression of the Neoplastic Phenotype by Replacement of the RB Gene in Human Cancer Cells." Science 242:1563-66 (1988).
Huang, et al., "A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product." Nature 350:160-162 (1991).
Huang, et al., "Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen." The EMBO Journal 9(6):1815-1822 (1990).
Hudson, et al., Practical Immunology, Blackwell Scientific Publications, 338-340 (1980).
Jansen, et al., "Successful Treatment of Human Acute T-Cell Leukemia in SCID Mice Using the Anti-CD7-deglycosylated Ricin A-Chain Immunotoxin DA7." Cancer Research 52:1314-1321 (1992).
Jeang, et al., "Abundant Synthesis of Functional Human T-Cell Leukemia Virus Type I p40.sup.x Protein in Eucaryotic Cells by Using a Baculovirus Expression Vector." Journal of Virology 61(3):708-713 (1987).
Kantoff, et al., "Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer." Proceedings of the National Academy of Sciences 83:6563-6567 (1986).
Kaye, et al., "A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding." Proceedings of the National Academy of Sciences 87:6922-6926 (1990).
Kitagawa, et al., "cdc2-like kinase is associated with the retinoblastoma protein." Onocogene 7:1067-1074 (1992).
Kuehn, et al., "A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice." Nature 326:295-298 (1987).
LaLande, et al., "Isolation of Human Chromosome 13-Specific DNA Sequences Cloned from Flow Sorted Chromosomes and Potentially Linked to the Retinoblastoma Locus." Cancer Genetics and Cytogenetics 13:283-295 (1984).
LaLande, et al., "Molecular Detection and Differentiation of Deletions in Band 13q14 in Human Retinoblastoma." Cancer Genet. Cytogenet. 23:151-157 (1986).
Lee, Eva Y-H.P., et al., "Inactivation of the Retinoblastoma Susceptibility Gene in Human Breast Cancers." Science 241:218-221 (1988).
Lee, et al., "Molecular cloning of the human esterase D gene, a genetic market of retinoblastoma." Proceedings of the National Academy of Sciences 83:6337-6341 (1986).
Lee, et al., "Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79." Proceedings of the National Academy of Sciences 85:6017-6021 (1988).
Lee, et al., "Human Retinoblastoma Susceptibility Gene: Cloning, Identification and Sequence." Science 235:1394-1399 (1987).
Lee, et al., "Purification, biochemical characterization, and biological function of human esterase D." Proceedings of the National Academy of Sciences 83:6790-6794 (1986).
Miller, et al., "Generation of Helper-Free Amphotropic Retroviruses That Transduce a Dominant-Acting, Methotrexate-Resistant Dihydrofolate Reductase Gene." Mol. Cell. Biol. 5(3):431-437 (1985).
Miller, et al., "Transfer of Genes into Human Somatic Cells Using Retrovirus Vectors." Cold Spring Harbor Symposia on Quantitative Biology LI:1013-1019 (1986).
Miller, et al., "A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): Gene transfer into cells obtained from humans deficient in HPRT." Proceedings of the National Academy of Sciences USA 80:4709-4713 (1983).
Miyamoto, et al., "Production of Human c-myc Protein in Insect Cells Infected with a Baculovirus Expression Vector." Molecular and Cell Biology 5(10): 2860-2865 (1985).
Mosier, et al., "Transfer of a functional human immune system to mice with severe combined immnodeficiency." Nature 335:256-259 (1988).
Murphree, A. Linn and Benedict, William F., "Retinoblastoma: Clues to Human Oncogenesis." Science 223:1028-1033 (1984).
Pendergast, et al., "Baculovirus expression of functional P210 BCR-ABL oncogene product." Oncogene 4:759-766 (1989).
Ramsay, et al., "Human Proto-Oncogene N-myc Encodes Proteins That Bind DNA." Molecular and Cellular Biology 6(12):4450-4457 (1986).
Ratajczak, et al., "In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides." Proceedings of the National Academy of Sciences 89:11823-11827 (1992).
Reissmann, et al., "Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer." Oncogene 8:1913-1919 (1993).
Sachse, et al., "DNA aberrations at the retinoblastoma gene locus in human squamous cells carcinomas of the lung." Oncogene 9:39-47 (1994).
Eliyahu, et al., "Wild-type p53 can inhibit oncogene-mediated focus formation." Proceedings of the National Academy of Sciences 86:8763-8767 (1989).
Friedmann, Theodore, "Gene Therapy of Cancer through Restoration of Tumor-Suppressor Functions?" Cancer 70:1810-1817 (1992).
Friedmann, Theodore, "Progress Toward Human Gene Therapy." Science 244:1275-1281 (1989).
Friend, et al., "Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: Organization of the sequence and its encoded protein." Proceedings of the National Academy of Sciences 84:9059-9063 (1987).
Friend, et al., "A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteos
Goodrich David W.
Johnson Duane
Lee Eva Y-H.P.
Lee Wen-Hwa
Shepard H. Michael
Canji Inc.
Grimes Eric
The Regents of the University of California
LandOfFree
Therapeutic use of the retinoblastoma susceptibility gene produc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic use of the retinoblastoma susceptibility gene produc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of the retinoblastoma susceptibility gene produc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2047756